What are the strengths and weaknesses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing catatonia disorder due to another medical condition?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comparative Analysis of DSM-5-TR and ICD-11 for Diagnosing Catatonia Due to Another Medical Condition

ICD-11 demonstrates superior clinical utility for diagnosing catatonia due to another medical condition, with 82.5-83.9% of clinicians rating it as quite or extremely easy to use, accurate, clear, and understandable, primarily due to its independent diagnostic status and explicit differential guidance. 1

Strengths of ICD-11

Conceptual Framework

  • ICD-11 conceptualizes catatonia as an independent disorder with a common clinical phenotype regardless of associated condition, representing a fundamental shift from viewing catatonia merely as a subtype of schizophrenia 2, 3
  • The system expanded from 11 to 21 disorder groupings in the mental, behavioral, and neurodevelopmental disorders chapter, providing more comprehensive classification 1
  • ICD-11 underwent the largest participative revision in classification history, with field studies demonstrating higher reliability and clinical utility compared to ICD-10 2

Diagnostic Criteria Specificity

  • ICD-11 requires at least 3 clinical features from three distinct categories: decreased psychomotor activity, increased psychomotor activity, or abnormal psychomotor activity, with features from any combination but only one from the increased activity category counted 2, 3
  • The system provides explicit guidance on distinguishing catatonia from similar behavioral features including psychomotor retardation in depression, delirium, and factitious disorder 2, 3
  • ICD-11 allows rating symptom severity across multiple domains at each assessment, enabling longitudinal tracking 1

Strengths of DSM-5-TR

Unified Diagnostic Approach

  • DSM-5-TR introduced a single set of criteria for catatonia across all psychiatric disorders, including stupor, catalepsy, waxy flexibility, mutism, and negativism 1
  • The system recognizes catatonia associated with several psychiatric and general medical conditions, broadly aligning with ICD-11 in terms of which items are included and item definitions 3, 4

Shared Weaknesses of Both Systems

Lack of Biological Validation

  • Neither DSM-5-TR nor ICD-11 has biological validation, resulting in biologically heterogeneous groups within the same diagnostic category 1
  • Both systems classify mental phenomena based on self-reported or clinically observable symptoms rather than underlying pathophysiology 1

Categorical Limitations

  • Both systems remain categorical at their core despite efforts toward dimensionality, with changes from previous versions being relatively modest 1
  • Arbitrary boundaries between diagnostic categories limit reliability and validity 1
  • The lack of item thresholds is a fundamental limitation in both DSM-5-TR and ICD-11 diagnostic criteria 4

Clinical Detection Challenges

  • Many distinctions across scales and criteria contribute to diagnostic discordance, making catatonia widely under-detected 4
  • Clear, consistent definitions for catatonia features remain inconsistent across different assessment tools 4

Critical Gaps in Both Systems

Geriatric Population Considerations

  • Both systems lack specific guidance for distinguishing catatonia from delirium in elderly patients, despite this being a critical clinical challenge 1
  • The overlap between catatonic features and age-related psychomotor changes is not adequately addressed 1

Differential Diagnosis Complexity

  • While ICD-11 provides better differential guidance than DSM-5-TR, both systems struggle with the presentation of acute onset psychomotor symptoms in the absence of mental illness history, requiring extensive workup to rule out medical causes 5

Recommended Improvements for Clinical Work and Research

Standardization of Assessment Tools

  • Implement the Bush-Francis Catatonia Rating Scale as the standard assessment tool, as it is the most efficient with a screening instrument, videographic resources, and standardized clinical assessment 4
  • Alternatively, adopt the Northoff scale for detailed assessment, which uniquely emphasizes emotional and volitional disturbances in catatonia 4

Enhanced Differential Guidance

  • Develop specific algorithms for distinguishing catatonia from delirium in elderly patients, addressing the critical gap identified in geriatric populations 1
  • Create explicit criteria for differentiating catatonia from psychomotor retardation in depression, particularly in medical settings where 3.3% of inpatients present with catatonia 6

Biological Marker Integration

  • Incorporate emerging neurobiological findings into future revisions to move beyond purely phenomenological classification 1
  • Develop biomarker-informed subtypes to address the biological heterogeneity within current diagnostic categories 1

Clinical Utility Enhancements

  • Mandate severity rating scales at each assessment point, building on ICD-11's framework for longitudinal tracking 1
  • Establish clear item thresholds for each catatonic feature to improve diagnostic reliability 4
  • Create standardized training modules using videographic resources to improve recognition rates, particularly given that catatonia remains unrecognized in an unknown number of patients at risk of life-threatening complications 6

References

Guideline

Diagnostic Systems for Catatonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Catatonia Diagnosis and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Catatonia in ICD-11.

BMC psychiatry, 2025

Research

Catatonia.

Nature reviews. Disease primers, 2024

Related Questions

What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing unspecified catatonia?
What are the changes in diagnosis of catatonic disorder due to another medical condition across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-TR (Text Revision), 4, 5, and 5-TR (Text Revision), and International Classification of Diseases (ICD) versions 10 and 11?
What are the changes in the diagnosis of catatonia associated with another mental disorder (catatonia specifier) across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-TR (Text Revision), 4, 5, and 5-TR (Text Revision), and International Classification of Diseases (ICD) versions 10 and 11?
What are the changes in diagnosis of unspecified catatonia disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-TR (Text Revision), 4, 5, and 5-TR (Text Revision), and International Classification of Diseases (ICD) versions 10 and 11?
What is the best course of treatment for an 80-year-old male patient presenting with catatonia?
What is the appropriate treatment for an adult patient with community-acquired pneumonia and thrombocytopenia?
What are the key differences in radiological findings between caecal (cecal) volvulus and sigmoid volvulus in elderly patients presenting with symptoms of intestinal obstruction?
Why is there no elevation of serum glutamic-oxaloacetic transaminase (SGOT) levels in a patient with tuberculosis (TB) of the liver?
What is the typical post-operative pain timeline for a patient undergoing rhinoplasty?
Do patients with Duchenne Muscular Dystrophy (DMD) have dystrophin?
What is the mortality rate for a patient with disseminated tuberculosis (TB) if left untreated versus treated with standard antitubercular drugs?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.